Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Sci-Tech Centre

Mar 21, 2014 9:00 AM - Mar 22, 2014 6:00 PM

7, Prabhatnagar, Jogeshwari (W), Mumbai 400102, MH, India

Conference on Pharmacovigilance & Drug Safety - A New Era

Session 4: An Insight into Cardiovascular, Hepatic and Renal Safety Issues During Drug Risk Benefit Management

Speaker(s)

Vishwas  Sovani

An insight into Cardiovascular, Hepatic and Renal Safety Issues During Risk Benefit Management

Vishwas Sovani

Revogenex, Inc., India

Milind  Sardesai

An insight into Cardiovascular, Hepatic and Renal Safety Issues During Risk Benefit Management

Milind Sardesai

Cognizant Technology Solutions India, India

GM - Medical Safety Services

Mangesh  Kulkarni, MD

An insight into Cardiovascular, Hepatic and Renal Safety Issues During Risk Benefit Management

Mangesh Kulkarni, MD

Tata Consultancy Services, India

Global Drug Safety - Physician and Head of Practice

Aaron  Cockell, MBA

Introduction to Medical Information and its Integration with Drug Safety

Aaron Cockell, MBA

AbbVie, United Kingdom

Medical Information Global Lead

Satya S S Sagi, MBA, MSc

IT Solutions for Efficient Medical Information Management

Satya S S Sagi, MBA, MSc

Techsol Life Sciences, United States

Founder & CEO

Mandar A. Kelkar

Cosmetic Vigilance

Mandar A. Kelkar

Tata Consultancy Services, India

Domain Lead, Safety Surveillance and Risk Management

Manoj  Swaminathan

Management of PV Challenges through Company Acquisitions and Mergers

Manoj Swaminathan

Piramal Enterprises Ltd, India

Chief Manager / Head Global Pharmacovigilance Center

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.